WEIBERTH, FRANZ J,GILL, HARPAL S,LEE, GEORGE,HILLEGASS, ANDREA,VANDEUSEN, CHRISTOPHER L
申请号：
NZ59909910
公开号：
NZ599099A
申请日:
2010.10.07
申请国别(地区):
NZ
年份:
2013
代理人:
摘要：
This disclosure is directed to a compound of formula (I): wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).
